Sarah Cavanaugh - Net Worth and Insider Trading
Sarah Cavanaugh Net Worth
The estimated net worth of Sarah Cavanaugh is at least $50,276 dollars as of 2024-11-13. Sarah Cavanaugh is the SVP OF CORP AFFAIRS & ADMIN. of Celldex Therapeutics Inc and owns about 1,860 shares of Celldex Therapeutics Inc (CLDX) stock worth over $50,276. Details can be seen in Sarah Cavanaugh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sarah Cavanaugh has not made any transactions after 2024-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sarah Cavanaugh
Sarah Cavanaugh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sarah Cavanaugh owns 1 companies in total, including Celldex Therapeutics Inc (CLDX) .
Click here to see the complete history of Sarah Cavanaugh’s form 4 insider trades.
Insider Ownership Summary of Sarah Cavanaugh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2024-05-30 | SVP of Corp. Affairs & Admin. |
Sarah Cavanaugh Latest Holdings Summary
Sarah Cavanaugh currently owns a total of 1 stock. Sarah Cavanaugh owns 1,860 shares of Celldex Therapeutics Inc (CLDX) as of May 30, 2024, with a value of $50,276.
Latest Holdings of Sarah Cavanaugh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2024-05-30 | 1,860 | 27.03 | 50,276 |
Holding Weightings of Sarah Cavanaugh
Sarah Cavanaugh Form 4 Trading Tracker
According to the SEC Form 4 filings, Sarah Cavanaugh has made a total of 5 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Celldex Therapeutics Inc is the sale of 20,853 shares on May 30, 2024, which brought Sarah Cavanaugh around $703,372.
Insider Trading History of Sarah Cavanaugh
- 1
Sarah Cavanaugh Trading Performance
GuruFocus tracks the stock performance after each of Sarah Cavanaugh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sarah Cavanaugh is 143.96%. GuruFocus also compares Sarah Cavanaugh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sarah Cavanaugh within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sarah Cavanaugh's insider trading performs compared to the benchmark.
Performance of Sarah Cavanaugh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 140.63 | | | | | |
| Relative Return to S&P 500(%) | 140.79 | | | | | |
Sarah Cavanaugh Ownership Network
Ownership Network List of Sarah Cavanaugh
Ownership Network Relation of Sarah Cavanaugh
Sarah Cavanaugh Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Sarah Cavanaugh is the SVP of Corp. Affairs & Admin. of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include director & President and CEO Anthony S Marucci , SVP & Chief Product Dev Officer Elizabeth Crowley , and SVP and CFO Samuel Bates Martin .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Sarah Cavanaugh made 1 insider transaction in Celldex Therapeutics Inc (CLDX) with a net sale of 20,853. Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 83,597 shares made by Elizabeth Crowley , a net sale of 97,088 shares made by Margo Heath-chiozzi , and a net sale of 52,172 shares made by Samuel Bates Martin .
In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 11,500 shares, with a net purchase of 11,500 shares. During the past 18 months, 353,560 shares of Celldex Therapeutics Inc (CLDX) were sold and 11,500 shares were bought by its insiders, resulting in a net sale of 342,060 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Sarah Cavanaugh Mailing Address
Above is the net worth, insider trading, and ownership report for Sarah Cavanaugh. You might contact Sarah Cavanaugh via mailing address: C/o Celldex Therapeutics, Inc., 53 Frontage Road, Suite 220, Hampton Nj 08827.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
